Team-Based Care for Cholesterol Management, A Practical Perspective from UCSF Cardiology.
You can view this informtion at the following link: https://youtu.be/wj4siiYJ97o
Overview:
Effective cholesterol management, particularly the reduction of low-density lipoprotein cholesterol (LDL-C) is a critical component in the prevention and treatment of cardiovascular disease. This program emphasizes the importance of a team-based approach to cholesterol management including bringing together physicians, pharmacists, dietitians, and other health care professionals to deliver coordinated patient centered care by leveraging the unique expertise of each team member. This cross-functional collaborative model can enhance treatment adherence, optimize therapeutic outcomes, ensure comprehensive patient assessment, and follow up.
The live lecture for this recording took place April 14, 2025.
 |
| Co-Chair, Right Care Initiative Silicon Valley University of Best Practices; Associate Professor, Cardiology, School of Medicine, University of California, San Francisco; Cardiologist, Cardiovascular Care & Prevention Center, University of California, San Francisco |
Speaker Bio:
Eveline Oestreicher Stock, MD
Dr. Stock’s expertise in Endocrinology and Cardiology at the University of California San Francisco have informed her exciting work in molecular cardiology. Dr. Stock is a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of atherosclerotic coronary heart disease. Her research interests include the role of lipoprotein subclasses as predictors of coronary artery disease and myocardial infarction. She is an Associate Professor at UCSF, a practicing cardiologist and lipidologist, and a researcher at the Cardiovascular Research Institute at UCSF. She received her medical education at the Catholic University of Chile and completed her training in endocrine hypertension and residency at Harvard Medical School’s Massachusetts General Hospital. She looks forward to continuing to work with the Right Care Initiative as a means of closing the gap between science and practice to get to zero heart attacks and strokes, especially in vulnerable populations.